Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, includingVEGFA, in human osteosarcoma

(2011) Jilong Yang et al.   CANCER

Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

(2011) J. Yang et al.   CLINICAL CANCER RESEARCH

Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2

(2011) Simone L. Ardern-Holmes et al.   Current Treatment Options in Neurology

Unlocking the Mdm2-p53 loop: Ubiquitin is the key

(2010) Hilary V. Clegg et al.   CELL CYCLE

Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

(2009) Changye Zou et al.   ANNALS OF SURGERY

Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors

(2009) Helge R. Brekke et al.   NEURO-ONCOLOGY

High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization

(2008) K. K. Mantripragada et al.   CLINICAL CANCER RESEARCH

Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations

(2008) Stephen R. Grobmyer et al.   JOURNAL OF SURGICAL ONCOLOGY

Malignant Peripheral Nerve Sheath Tumors

(2008) Gaurav Gupta et al.   NEUROSURGERY CLINICS OF NORTH AMERICA